Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension is a compounded liquid medication. It is uniformly mixed to ensure a homogeneous mixture for administration. This medication is used to treat conditions such as Gastroesophageal Reflux Disease, Dyspepsia, Peptic Ulcer Disease, Postpartum Hemorrhage, and Menorrhagia.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized compounded formulation of Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension. This unique formulation is specifically designed to address a range of conditions such as Gastroesophageal Reflux Disease (GERD), Dyspepsia, Peptic Ulcer Disease, Postpartum Hemorrhage, and Menorrhagia.
Misoprostol, a prostaglandin E1 analog, functions to decrease gastric acid secretion and safeguard the gastric mucosa from potential damage. Lidocaine HCl, on the other hand, is an anesthetic that effectively reduces the pain and discomfort associated with these conditions.
This formulation is a liquid dosage form in which the active ingredients, Misoprostol and Lidocaine HCl, are uniformly dispersed throughout a liquid medium. This ensures a homogeneous mixture for administration, making it easy for patients to take and ensuring consistent dosing.
Patients are advised to take the medication as directed by their healthcare provider to ensure optimal results. If you have any queries regarding this formulation or how it can assist in managing your condition, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive pharmaceutical care and are always ready to address your concerns.
This compounded formulation of Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension is a liquid dosage form that provides a homogeneous mixture for administration. It is primarily used in the treatment of Gastroesophageal Reflux Disease, Dyspepsia, Peptic Ulcer Disease, Postpartum Hemorrhage, and Menorrhagia. It is crucial to understand that this formulation is contraindicated in patients with known hypersensitivity to either Misoprostol or Lidocaine HCl. It should also be avoided in patients with a history of gastrointestinal bleeding or cardiac arrhythmias.
Patients taking this formulation should be closely monitored for signs and symptoms of gastrointestinal bleeding and arrhythmias. There is also a potential risk of anaphylaxis, and patients should be observed for any signs and symptoms of this severe allergic reaction. Immediate medical attention should be sought if any of these symptoms occur.
Patients are advised to abstain from alcohol while taking this formulation, as it may increase the risk of gastrointestinal bleeding. It is also important to avoid other medications that may interact with this formulation, such as anticoagulants, antiplatelet agents, and nonsteroidal anti-inflammatory drugs. If you have any questions about this formulation or its potential interactions, please do not hesitate to reach out for further information.
Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension is a specially compounded medication designed to address a range of conditions such as Gastroesophageal Reflux Disease, Dyspepsia, Peptic Ulcer Disease, Postpartum Hemorrhage, and Menorrhagia. This formulation contains two active ingredients: Misoprostol and Lidocaine HCl.
Misoprostol is a prostaglandin E1 analog that functions by reducing the production of stomach acid and enhancing the production of protective mucus in the stomach. This helps to alleviate symptoms associated with conditions like Gastroesophageal Reflux Disease, Dyspepsia, and Peptic Ulcer Disease. On the other hand, Lidocaine HCl is an anesthetic that works by numbing the area where it is applied, providing relief from pain and discomfort.
When administered orally, Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension is absorbed into the bloodstream and distributed throughout the body. The active ingredients then target the affected areas, providing symptomatic relief. For conditions like Postpartum Hemorrhage and Menorrhagia, the medication works to reduce the amount of bleeding and alleviate associated pain.
Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension is a appropriate treatment option for the aforementioned conditions. However, it is crucial to adhere to the instructions provided by your healthcare provider when taking this medication. If you have any queries or concerns about this formulation, please do not hesitate to reach out to your healthcare provider or pharmacist.
Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension is a compounded formulation that serves multiple therapeutic purposes. It is a liquid dosage form that ensures a uniform dispersion of the active ingredients, providing a homogeneous mixture for administration. This formulation may be used to treat a variety of conditions including postoperative pain, oral mucositis, and other oral lesions. It can be used as an adjunct to other treatments for these conditions, enhancing their effectiveness.
Furthermore, this formulation may be used to reduce the risk of gastric ulceration in patients taking nonsteroidal anti-inflammatory drugs (NSAIDs). It can also be used to mitigate the risk of postpartum hemorrhage in women who have undergone a cesarean section. Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension may also be beneficial in reducing the risk of menorrhagia in women with heavy menstrual bleeding.
Additionally, it may be used to reduce the risk of dyspepsia in patients taking NSAIDs. It can also be beneficial in reducing the risk of gastroesophageal reflux disease in patients taking NSAIDs. If you have any questions about the use of Misoprostol 0.0024%/Lidocaine HCl 1% Oral Suspension for any of these conditions, please do not hesitate to reach out for more information.
This is a compounded formulation that combines Misoprostol and Lidocaine HCl in a liquid dosage form. The ingredients are uniformly dispersed throughout a liquid medium, providing a homogeneous mixture for administration.
Misoprostol is a medication used to prevent stomach ulcers in patients who are also taking nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing the amount of acid that the stomach produces.
Lidocaine HCl is a local anesthetic that works by causing temporary numbness/loss of feeling in the skin and mucous membranes. It is used to decrease pain or discomfort caused by minor skin irritations, sore throat, sunburn, teething pain, vaginal or rectal irritation, and other conditions.
This oral suspension should be stored at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
The dosage is based on your medical condition and response to treatment. It's important to use this medication exactly as directed by your healthcare provider.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Before starting this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of other local anesthetics. This document does not contain all possible interactions.
Common side effects may include nausea, vomiting, diarrhea, or upset stomach. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: heart disease, liver disease, kidney disease, other stomach problems (e.g., tumors).
This medication should not be used during pregnancy or while breastfeeding without the advice of your healthcare provider. Misoprostol can cause abortion, premature birth, or birth defects if taken during pregnancy.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
